The literature shows evidence of progress in research focusing on the delin
eation of the biological mechanisms responsible for cross-ethnic variations
in psychotropic metabolism and effects. This article starts with a brief s
ummary of some of the new developments in pharmacogenetics, focusing on the
ir relevance in the practice of psychopharmacology. This is followed by a d
iscussion on gene-environment interactions and their implication in the cul
tural context. In addition, clinicians should begin to develop a good grasp
on the meaning of the variations of the genes that encode therapeutic targ
ets of psychotropics (i.e., neurotransmitter transporters and receptors). F
inally, the importance of culture and ethnicity in influencing patients' ps
ychopharmacologic response is also discussed.